Naoya Sakamoto

24PUBLICATIONS
95CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 27, 2026
Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

|Dec 16, 2025
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness.

Shunta Tsuchida, Tetsuro Taki, Kotaro Nomura

|Jul 24, 2025
Evaluating peritoneal elastic laminal invasion to improve stratification of patients with pT3 gastric cancer.

Daiki Terajima, Motohiro Kojima, Shingo Sakashita

|Jun 02, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.

Tadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura

|Feb 21, 2025
PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer.

Kenji Harada, Naoya Sakamoto, Takumi Kitaoka

|Jan 14, 2025
Area of Residual Tumor Measurement After Preoperative Chemotherapy as an Objective and Quantitative Method for Predicting the Prognosis of Gastric Cancer: A Single-Center Retrospective Study.

Hiromi Nagata, Takahiro Kinoshita, Shingo Sakashita

Pageof 4

Frequent Collaborators

12 joint publications

Genichiro Ishii

10 joint publications

Motohiro Kojima

5 joint publications

Shingo Sakashita

5 joint publications

Kohei Shitara